Home BancShares Reports Strong Q4 2025 Earnings with 18% Net Income Growth and Record Loan Volume
HOMB sits 16% above its 52-week low of $24.22 on elevated volume (1.8× avg).
Summary
Home BancShares reported strong Q4 2025 earnings with an 18% year-over-year net income increase, record loan growth, and improved efficiency, alongside a dividend hike.
Key Events · Earnings and Guidance · HOMB
-
Strong Q4 & Annual Performance
Net income for Q4 2025 rose to $118.2 million, an 18% increase year-over-year, contributing to a record annual net income of $475.4 million for 2025.
-
Diluted EPS Growth
Diluted earnings per share for Q4 2025 was $0.60, up 17.6% year-over-year, with annual DEPS increasing 20% to $2.41.
-
Record Loan Growth
The company achieved $400.2 million in loan growth during Q4 2025, reaching a record total loans receivable of $15.69 billion.
-
Improved Efficiency & Margin
The efficiency ratio improved to 39.54% in Q4 2025, while the net interest margin expanded to 4.61%.
Analysis · HOMB · Finance
Home BancShares delivered robust fourth-quarter and full-year 2025 results, showcasing significant financial and operational improvements. The company achieved an 18% year-over-year increase in net income and a 20% rise in diluted EPS for the full year, driven by strong loan growth and improved efficiency. The expansion of its net interest margin and reduction in non-performing assets further highlight its solid financial health. The dividend increase signals confidence in future performance.
How filings like this one have moved
In the 30 days to Sep 21, 2026, 34.9% of the 1003 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, HOMB was trading at $28.00 on NYSE in the Finance sector, with a market capitalization of approximately $5.6B. The 52-week trading range was $24.22 to $31.27. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.